
Torrent Pharmaceuticals Ltd.
Torrent Pharma
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Large-cap - With a market cap of ₹1282.45 Cr.
| EX-Date | Purpose |
|---|---|
| 18 05 2021 | Audited Results & Final Dividend Inter alia, the Board would also consider the following: i. Payment of Final Dividend for the year 2020-21. ii. Taking enabling resolutions for raising of funds by issue of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) and / or Depository Receipts or any other modes. If approved by the Board of Directors, the said item will be placed for Shareholders approval in the ensuing Annual General Meetin |
| 27 07 2021 | Quarterly Results |
| 26 10 2021 | Quarterly Results |
| 25 01 2022 | Quarterly Results & Interim Dividend |
| 25 05 2022 | Final Dividend & Bonus issue & Audited Results |
| 29 07 2022 | Quarterly Results |
| 21 10 2022 | Quarterly Results |
| 25 01 2023 | Quarterly Results & Interim Dividend |
| 30 05 2023 | Final Dividend & Audited Results |
| 07 08 2023 | Quarterly Results |
| 23 10 2023 | Quarterly Results |
| 02 02 2024 | Quarterly Results & Interim Dividend |
| 25 10 2024 | Quarterly Results |
| 24 01 2025 | Quarterly Results & Interim Dividend |
| 20 05 2025 | Final Dividend & Audited Results |
| 28 07 2025 | Quarterly Results & Inter alia, will also consider the Issue of Unsecured or Secured Redeemable Non Convertible Debentures or Bonds by way of private placement. |
| 07 11 2025 | Quarterly Results |
